Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis 9989

Max Ratio

Dividend Yield

5.07 %

5Y Dividend Growth

0.00 %

Consecutive Years

5Y Average Payout Ratio

53.95 %

Dividend History 9989

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 5.07 %
Consecutive Years 0
Forward Annual Dividend 0.27 HKD
Consistent Years 0
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM 89.54 %
Dividend CAGR 10Y
Ex Dividend Date 05/26/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth 9989

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin 9989

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income 9989

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM 9989

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio 9989

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Shenzhen Hepalink Pharmaceutical  9989

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself 9989

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 17.19
Forward PE
Enterprise Value Revenue 2.86
Price Sales TTM 3.24
Enterprise Value EBITDA 27.34
Price Book MRQ 0.57

Shenzhen Hepalink Pharmaceutical  Dividends: 5.07 % Yield, History, Payment Schedule

9989
Current price
5.36 HKD -0.04 HKD (-0.74%)
Last closed 5.40 HKD
ISIN CNE100003YN2
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Hong Kong Stock Exchange
Capitalization 17 434 388 923 HKD
Yield for 12 month +31.05 %
1Y
3Y
5Y
10Y
15Y
9989
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+5 282 456 601 HKD

Last Year

+5 447 369 665 HKD

Current Quarter

+1 423 566 895 HKD

Last Quarter

+1 394 710 296 HKD

Current Year

+1 756 734 877 HKD

Last Year

+1 800 897 598 HKD

Current Quarter

+496 971 263 HKD

Last Quarter

+381 307 645 HKD
EBITDA 875 603 571 HKD
Operating Margin TTM 14.64 %
Price to Earnings 17.19
Return On Assets TTM 2.22 %
PEG Ratio
Return On Equity TTM 3.23 %
Wall Street Target Price 33.60 HKD
Revenue TTM 5 386 236 699 HKD
Book Value 8.43 HKD
Revenue Per Share TTM
Dividend Share 0.25 HKD
Quarterly Revenue Growth YOY 11.80 %
Dividend Yield 5.07 %
Gross Profit TTM 1 711 245 023 HKD
Earnings per share 0.29 HKD
Diluted Eps TTM 0.29 HKD
Most Recent Quarter II 2025
Quarterly Earnings Growth YOY 13.10 %
Profit Margin 7.80 %

Technical Indicators 9989

For 52 Weeks

3.35 HKD 7.26 HKD
50 Day MA 5.51 HKD
Shares Short Prior Month
200 Day MA 5.25 HKD
Short Ratio
Shares Short
Short Percent